MICHAEL BILLOCK: Open Payments
NPI 1962164046 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,069 in 53 payments from 7 companies in 2025. Trend: 2023 $860 · 2024 $1,127 · 2025 $1,069
Food & beverage: $1,069
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $297 |
| Otsuka America Pharmaceutical, Inc. | 15 | $254 |
| Janssen Pharmaceuticals, Inc | 5 | $199 |
| Teva Pharmaceuticals USA, Inc. | 15 | $191 |
| Lundbeck LLC | 5 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
Products named: COBENFY, REXULTI, INVEGA SUSTENNA, AUSTEDO XR, UZEDY, ABILIFY MAINTENA, ABILIFY ASIMTUFII, CAPLYTA.
Industry payments across OH — which companies pay providers there.
